Association of CCL2 with lymph node metastasis and macrophage infiltration in oral cavity and lip squamous cell carcinoma

Tumor Biology

Volumn 29, Issue 2, 2008, Pages 114-121

  Ferreira, Fernanda Oliveira ^a   Ribeiro, Fernanda Luiza Leite ^b   Batista, Aline Carvalho ^b   Leles, Cláudio Rodrigues ^b   De Cássia Gonçalves Alencar, Rita ^c   Silva, Tarcília Aparecida ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c Araujo Jorge Hospital   (Brazil)

Author keywords

CCL2; Chemokine; Lymph node; Macrophage; Metastasis; Squamous cell carcinoma

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL COUNT; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIP CARCINOMA; LYMPH NODE METASTASIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; PARENCHYMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

EID: 47949122227     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000137669     Document Type: Article

References (21)

1. Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 2000;6:3282-3289.
2. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow? Lancet 2001;357:539-545.
3. Vicari AP, Caux C: Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143-154.
4. Conti I, Rollins BJ: CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 2004;14:149-154.
5. Karnoub AE, Weinberg RA: Chemokine networks and breast cancer metastasis. Breast Dis 2006-2007;26:75-85.
6. Sica A, Schioppa T, Mantovani A, Allavena P: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006;42:717-727.
7. Silva TA, Ribeiro FL, Oliveira-Neto HH, Watanabe S, Gonçalves Alencar RC, Fukada SY, Cunha FQ, Leles CR, Mendonça EF, Batista AC: Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense. Oncol Rep 2007;18:1107-1113.
8. Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K, Toi M: Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 2001;92:1085-1091.
9. Ohta M, Kitadai Y, Tanaka S, Yoshihara M, Yasui W, Mukaida N, Haruma K, Chayama K: Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human esophageal squamous cell carcinomas. Int J Cancer 2002;102:220-224.
10. Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J: CCR2 expression correlates with prostate cancer progression. J Cell Biochem 2007;101:676-685.
11. Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, Di Carlo V, Allavena P, Piemonti L: The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res 2003;63:7451-7461.
12. Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S: Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 2004;99:1667-1674.
13. Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A, Mantovani A, Mordoh J, Wainstok R: Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 2007;127:2031-2041.
14. Nokihara H, Yanagawa H, Nishioka Y, Yano S, Mukaida N, Matsushima K, Sone S: Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice. Cancer Res 2000;60:7002-7007.
15. Nesbit M, Schaider H, Miller TH, Herlyn M: Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. J Immunol 2001;166:6483-6490.
16. Muller A, Sonkoly E, Eulert C, Gerber PA, Kubitza R, Schirlau K, Franken-Kunkel P, Poremba C, Snyderman C, Klotz LO, Ruzicka T, Bier H, Zlotnik A, Whiteside TL, Homey B, Hoffmann TK: Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int J Cancer 2006;118:2147-2157.
17. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ: Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000;96:34-40.
18. Marcus B, Arenberg D, Lee J, Kleer C, Chepeha DB, Schmalbach CE, Islam M, Paul S, Pan Q, Hanash S, Kuick R, Merajver SD, Teknos TN: Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004;101:2779-2787.
19. Lebrecht A, Grimm C, Lantzsch T, Ludwig E, Hefler L, Ulbrich E, Koelbl H: Monocyte chemoattractant protein-1 serum levels in patients with breast cancer. Tumour Biol 2004;25:14-17.
20. Müller R, Zheng M, Mrowietz U: Significant reduction of human monocyte chemotactic response to monocyte-chemotactic protein 1 in patients with primary and metastatic malignant melanoma. Exp Dermatol 1997;6:81-86.
21. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ: Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000;404:407-411